Libra Therapeutics
2 known investors
Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease. The company's approach aims to restore cellular balance by enhancing the body's natural ability to clear toxic proteins and dysfunctional organelles.
Founders & leadership
DG
Dr. GillChief Scientific Officer
Investors Β· 2
Frequently asked questions
- What does Libra Therapeutics do?
- Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease. The company's approach aims to restore cellular balance by enhancing the body's natural ability to clear toxic proteins and dysfunctional organelles.
- Who are Libra Therapeutics's investors?
- Libra Therapeutics's investors include Epidarex Capital, Dolby Family Ventures.